Nvidia insiders sold over $1 billion in stock amid market surge, FT reports More than $500 million of the share sales took place this month Published: Sun 29 Jun 2025, 7:52 PM By: Reuters ...

Global oil benchmark Brent crude climbed 1.21 per cent to USD 67.95 a barrel. Foreign Institutional Investors offloaded equities worth ₹ 5,266.01 crore on Tuesday, according to exchange data.

L ucknow: Buying residential and commercial properties in Lucknow will soon be a costly affair as the district administration is set to implement revised circle rates from Aug 1. The new rates ...

Nvidia’s stock hit a record on Wednesday, and the chipmaker reclaimed the crown as the world’s most valuable company after an analyst said the chipmaker was set to ride a “Golden Wave” of ...

Initially used to treat type 2 diabetes, semaglutide now also helps to treat obesity. People using the jab can lose up to 20% of their body weight due to the drug suppressing the hunger hormone, ...

In today's trading session, Godrej Properties shares demonstrated a notable increase, rising by 1.72% to reach Rs 2421.00.

Vertex Pharmaceuticals, a US-based drugmaker known for transformative therapies, is developing a new treatment called Zimislecel (formerly VX-880) that could revolutionize how Type 1 Diabetes (T1D ...

More information: Mugdha V. Joglekar et al, A microRNA-based dynamic risk score for type 1 diabetes, Nature Medicine (2025). DOI: 10.1038/s41591-025-03730-7 ...

(Reuters) -Nvidia insiders sold over $1 billion worth of company stock in the past year, with a notable uptick in recent trading activity as executives capitalize on surging investor interest in ...

According to a recently published report from Dell’Oro Group, 1Q 2025 worldwide Ethernet Campus Switch revenues grew by 3% year-over-year (Y/Y), with a sharp contraction in China pulling down ...

People with type 1 diabetes require insulin therapy for life, but the side effects can include weight gain and chronic kidney disease. Results from the new trial show that the combination therapy ...

TUESDAY, June 24, 2025 (HealthDay News) — A single infusion of a new stem cell-based treatment may have helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report.